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DNA damage during S-phase mediates the
proliferation-quiescence decision in the subsequent
G1 via p21 expression
Alexis R. Barr1,*, Samuel Cooper1,2,*, Frank S. Heldt3,*, Francesca Butera1, Henriette Stoy1, Jo¨rg Mansfeld4,
Be´la Nova´k3 & Chris Bakal1
Following DNA damage caused by exogenous sources, such as ionizing radiation, the tumour
suppressor p53 mediates cell cycle arrest via expression of the CDK inhibitor, p21. However,
the role of p21 in maintaining genomic stability in the absence of exogenous DNA-damaging
agents is unclear. Here, using live single-cell measurements of p21 protein in proliferating
cultures, we show that naturally occurring DNA damage incurred over S-phase causes
p53-dependent accumulation of p21 during mother G2- and daughter G1-phases. High
p21 levels mediate G1 arrest via CDK inhibition, yet lower levels have no impact on
G1 progression, and the ubiquitin ligases CRL4Cdt2 and SCFSkp2 couple to degrade p21 prior to
the G1/S transition. Mathematical modelling reveals that a bistable switch, created
by CRL4Cdt2, promotes irreversible S-phase entry by keeping p21 levels low, preventing
premature S-phase exit upon DNA damage. Thus, we characterize how p21 regulates the
proliferation-quiescence decision to maintain genomic stability.
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C
ell cycle regulation balances the requirement of prolifera-
tion during tissue growth and homeostasis, with the
need to ensure that damaged DNA is not propagated to
future generations. Checkpoints have evolved to achieve control
of cell cycle progression in response to DNA damage.
The importance of DNA damage checkpoints is highlighted
by the fact that their dysregulation is the fundamental basis
of oncogenesis1.
The tumour suppressor and transcriptional regulator p53 is
stabilized in response to DNA damage and regulates the
expression of numerous target genes involved in the
DNA damage response2,3. Amongst the transcriptional targets
of p53 is the Cyclin-dependent kinase (CDK) inhibitor p21
(refs 4,5). By inhibiting CDK activity, p21 mediates cell cycle
arrest6,7 downstream of p53, in response to DNA damage caused
by exogenous sources, such as ionizing irradiation or chemical
agents5,8,9. However, the role of p21 in cell cycle control in cells
proliferating in the absence of such DNA damage is less clear.
Moreover, whether p21 acts as a tumour suppressor in vivo is
controversial10. For example, in p21 knockout (KO) mice exposed
to exogenous DNA damage, both accelerated11–14 and inhibited15
tumourigenesis have been observed. However, the fact that
p21KO mice develop spontaneous tumours15, albeit later than
p53-deﬁcient mice16, demonstrates that p21 plays an essential
role in maintaining genomic stability.
Live measurements of p53 protein levels have shown that
unperturbed cells exhibit transient pulses of p53 expression17,
suggesting that DNA damage is occurring in these cells. In
response to transient p53 pulses, cells continue to cycle, yet more
frequent pulses or sustained p53 signalling causes cells to arrest or
undergo apoptosis18; thus mechanisms exist to temporally
integrate DNA damage levels and p53 signalling19,20. Previous
work in unperturbed cycling cells has also demonstrated that
bifurcation in CDK2 activity after mitosis causes a subpopulation
of cells to enter a p21-dependent G1 post-mitotic (pm) arrest
state, prior to restriction point (RP) passage21,22. Taken together,
we hypothesized that p53 signalling, in cells not exposed
to exogenous DNA damage, could generate heterogeneity in
p21 levels which, in turn, mediates the proliferation-quiescence
decision in single cells. This would prevent the propagation
of DNA damage to future generations and explain the importance
of p21 in maintaining genomic stability.
Using a live single-cell imaging approach, we show that
DNA damage accrued during S-phase, in non-transformed
cycling cells, results in heterogeneity in p21 levels that is
p53-dependent. We ﬁnd that p21 accumulates during mother
G2- and daughter G1-phases, where it modulates the prolifera-
tion-quiescence decision in daughter cells via CDK2 inhibition.
Strikingly, we ﬁnd that p21 accumulation below a threshold does
not inﬂuence G1 progression. At these lower levels of p21, two
ubiquitin ligases, CRL4Cdt2 and SCFSkp2, couple to remove
p21 prior to the G1/S transition with markedly different rates.
By combining single-cell measurements with mathematical
modelling, we show that this p21 control system has the
hallmarks of bistability, ensuring that the G1/S transition
is irreversible. Our data therefore support a model in which
p21 mediates a p53-dependent G1pm arrest in response to
DNA damage occurring in S-phase.
Results
Cells exhibit cell-to-cell variability in p21 expression. To
quantify p21 protein levels over time in live cells, we introduced
a GFP tag into the C-terminus of both alleles of the endogenous
CDKN1A gene (Fig. 1a; Supplementary Fig. 1a,b). Gene-targeting
was performed in an hTert-RPE1 cell line expressing one allele of
endogenously tagged mRuby-PCNA (proliferating cell nuclear
antigen). This allowed us to accurately track cells and correlate
changes in p21 with cell cycle phase (Fig. 1b; Supplementary
Movie 1). p21-GFP was exclusively nuclear, matching the loca-
lization of endogenous p21 in hTert-RPE1 cells (Supplementary
Fig. 1c). Population growth kinetics and cell cycle timing were
unaffected by introduction of the GFP tag into p21, and p21-GFP
is able to bind CDK2 (Supplementary Fig. 1d–f). Further con-
ﬁrmation that p21 function is retained by p21-GFP is that cells
expressing p21-GFP are able to enter G1 arrest in high-serum
growth conditions (Fig. 1f), whereas p21siRNA and p21KO cells
are not (Fig. 2b).
Live cell tracking revealed marked cell-to-cell variability in
p21-GFP levels amongst G1 and G2 hTert-RPE1 cells, within
the same population (Fig. 1c). This variability was also seen
in hTert-RPE1 cells ﬁxed and immunostained for unlabelled
p21 (Supplementary Fig. 2a). G1 cells have the highest and
most variable p21-GFP levels, and there exists a strong
correlation between p21-GFP levels and G1 phase length
(R¼ 0.62**; Fig. 1d). G2 is associated with lower and less variable
p21-GFP levels and correlation between G2 length and p21-GFP
levels is weaker than in G1 (R¼ 0.51**; Supplementary Fig. 2b).
Cells express undetectable levels of p21-GFP during S-phase
(Fig. 1c), consistent with previous reports23,24. We do not
observe p21-GFP degradation during mitosis, and mitotic
p21-GFP expression does not affect mitotic timing (Suppleme-
ntary Fig. 2c,d).
The lack of p21 degradation during mitosis would allow
daughter cells to inherit p21 protein from their mother. Indeed,
there is a positive correlation between p21-GFP levels in the
mother cell G2 (G2M) and daughter cell G1 (G1D; R¼ 0.75**;
Supplementary Fig. 2e). Moreover, G1D p21-GFP levels in sister
cells are positively correlated (R¼ 0.81**), as well as G1D length
between sisters (R¼ 0.53**; Fig. 1e). Despite the strong correla-
tion in p21-GFP levels in G2M with p21-GFP levels in G1D, the
phase lengths of G2M and G1D correlate poorly (R¼ 0.07,
P¼ 0.36 Pearson’s Correlation). Instead, we ﬁnd G1D p21-GFP
levels correlate better with combined G2MþG1D length
(R¼ 0.68**) than with G1D length alone (R¼ 0.62**) suggesting
that G2M length is not predictive of G1D because of noise in the
timing of mitotic entry (Methods). As such, we ﬁnd that the
maximum p21-GFP level reached in G1D is most reﬂective of the
time between S-phase exit in the mother cell and S-phase entry in
daughter cells. Given that much weaker correlations are observed
between phase lengths before and after S-phase (Methods),
we suggest that stochastic events occurring in S-phase determine
p21 levels in, and the length of, the combined G2MþG1D phase.
Although p21-GFP levels begin to rise during G2, p21-GFP
levels further increase after mitosis (Fig. 1b,c,f). In 21% (47/219)
of G1 cells, p21-GFP accumulates to a high level shortly after
mitosis and these cells enter a state we deﬁne as G1pm arrest25
(Fig. 1f; G1 length4600min). Cells with high p21-GFP
expression have hypo-phosphorylated pRb (Supplementary
Fig. 2f). Thus we propose that G1pm cells with high p21-GFP
levels are blocked before RP passage.
Consistent with p21 levels being inherited by daughter cells,
simple linear regression between the maximum p21-GFP level in
G2M and G1pm arrest demonstrated a positive correlation
(R¼ 0.43**). Following both daughter cells after mitosis, in
70% (45/64) of cases both daughters cycle, in 16% (10/64)
both daughter cells enter a G1pm arrest (twin arrest), while
in 14% (9/64), one daughter arrests and the other cycles
(single arrest). If arrest occurred by chance following mitosis,
we would expect fewer than 4.4% of mitoses to result in twin
arrest (21% chance of any cell arresting, 0.212¼ 0.044). As such,
conditions leading to arrest are frequently inherited by both
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daughter cells. Finally, where either single or twin arrest occurs in
daughter cells, mean G2M p21-GFP levels are higher than those
in G2M of cycling daughter cells (twin arrest¼ 9.6 a.u.; single
arrest¼ 8.0 a.u.; cycling¼ 5.9 a.u.; Fig. 1g). Thus, we propose that
factors contributing to G1pm arrest are detected prior to mitosis,
and the single arrest we observe is caused by asymmetric
inheritance of these factors; though p21 levels can increase further
in G1 to promote G1pm arrest. These observations suggest
that the proliferation-quiescence decision in G1, in unperturbed
cells, is regulated by p21 levels, which in turn are determined by
events occurring in the mother cell S-phase.
p53 drives p21 heterogeneity in unperturbed conditions.
We sought to determine factor(s) driving heterogeneity in p21
levels. Multiple transcription factors have been linked to p21
regulation10; the best characterized being p53. Depletion of
p53 by siRNA resulted in a large reduction in basal p21-GFP
levels, compared to control siRNA (Fig. 2a; Supplementary
Fig. 3a–c). Furthermore, G1 length became more homogeneous
(Fig. 2a) and no cells analysed entered G1pm arrest (Fig. 2b).
Thus, both G1pm arrest and G1 delay are p53-dependent, and
p53 signalling is necessary for p21 accumulation in hTert-RPE1
cells.
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Figure 1 | Cells exhibit cell-to-cell variability in p21 expression. (a) Image of p21-GFP (magenta) and mRuby-PCNA (turquoise) expressing hTert-RPE1
cells. Scale bar is 10mm. (b) Cell features captured by automated image analysis (Methods) from a single cell expressing mRuby-PCNA and p21-GFP.
(c) Single-cell traces of p21-GFP levels aligned to S/G2; n¼ 51 cells. Tracks are coloured according to p21-GFP intensity. Black circles represent mitosis.
(d) Correlation between maximum G1 p21-GFP intensity and G1 length (Pearson’s Correlation R¼0.62** (Po0.01)). Three different 488 nm exposures are
shown: Exp1, n¼ 206 cells; Exp2, n¼90; Exp3, n¼ 52 (Methods). (e) Correlation in G1 p21-GFP levels between sister cells—G1 Daughter1 (G1D1) and
G1 Daughter2 (G1D2; n¼ 62, Pearson’s Correlation R¼0.81** (Po0.01)). Data points are coloured to represent correlation between G1 length in
each daughter cell, calculated as the difference between the maximum and minimum G1 length divided by the sum of the sister G1 lengths, n¼ 62.
(f) Single-cell traces of p21-GFP levels aligned to mitotic exit; n¼ 51 cells. Grey line marks 600min time point used to deﬁne G1pm arrest. Red curves are
cells that enter a G1pm arrest, blue curves are cells that enter S-phase (cycle). (g) Mean p21-GFP intensity in G2M separated by daughter cell fate: cycling,
n¼49 cells; single arrest, n¼9; twin arrest, n¼ 10. Signiﬁcant differences are observed between arrested and cycling states using a two-sample t-test on
log-transformed data. Error bar is s.d. *Po0.05, **Po0.01.
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We further analysed the dependence of p21 expression on
p53 by adding the inhibitor Nutlin-3 to stabilize p53 protein26.
On Nutlin-3 addition, we see a net increase in p21-GFP
expression (Supplementary Fig. 3d). However, p21-GFP shows
a cell cycle phase-dependent response to Nutlin-3. Nutlin-3-
treated cells in G1 or G2 accumulate p21-GFP continuously and
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Figure 2 | p53 drives p21 heterogeneity in unperturbed conditions. (a) p21-GFP levels versus G1 length after siRNA treatment: control siRNA (blue),
n¼ 75 cells; p53 siRNA (yellow), n¼81; or p21 siRNA (red), n¼ 90. (b) Percentage of cells arresting in G1 for three siRNA treatments and for p21WT
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on G2 entry after Nutlin-3 addition to cells in S-phase. Black circles represent mitosis. Arrest, red, n¼ 19 cells; Mitosis, blue, n¼ 28. (e) CDK2 activity
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shows a period in G1 where CDK2 activity is increasing despite expression of p21-GFP. Traces aligned to S-phase entry at t¼0min. p21-GFP levels are
shown in green and CDK2 activity is shown in red. (g) Single-cell trace of CDK2 activity and p21-GFP levels in an unperturbed cell arrested in G1. p21-GFP
levels are shown in green and CDK2 activity is shown in red. Note: different scale for p21-GFP y-axis compared to (f).
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arrest in G1 (Fig. 2c), while cells in S-phase maintain low
p21-GFP during S-phase, before rapidly accumulating p21-GFP
after the S/G2 transition (Fig. 2c; Supplementary Movies 2,3).
In these cells we observe that G2 arrest correlates with the rate
of p21-GFP accumulation, meaning that cells with the highest
rate of p21-GFP accumulation arrest in G2, while cells
accumulating p21-GFP more slowly undergo mitosis before
entering a G1pm arrest (Fig. 2d; Methods).
G1pm arrest is p21-dependent but G1 delay is p21-independent.
Since p21-GFP levels correlate with G1 length, and depletion of
p53 leads to a more homogenous G1 length, we sought to
determine if p21 regulates G1 length. Following p21 depletion by
siRNA, only 7% (5/75) of p21-depleted cells entered a G1pm
arrest, compared to 17.2% (11/64) of control siRNA-treated cells
(Fig. 2b), but we saw no change in G1 length distribution
(Fig. 2a). To conﬁrm the effect of depleting p21 by siRNA, we
generated CRISPR/Cas9 deletions in the CDKN1A gene using two
different gRNAs, p21KO1 and p21KO2 (Supplementary Fig. 3e;
Supplementary Note 1). We observed only one p21KO cell
entering G1pm arrest (1/172; Fig. 2b), in spite of our observation
that p21KO cells have increased levels of DNA damage, as
measured by gH2AX levels (Supplementary Fig. 3f). As observed
following p21 depletion by siRNA, p21KO in two independently
generated clones did not change G1 length (Supplementary
Fig. 3g). As such, we ﬁnd that heterogeneity in G1 length is
p53-dependent but p21-independent, while G1pm arrest is both
p21- and p53-dependent. Moreover, that cells lacking p21 have
increased levels of DNA damage suggests that p21 is important
in maintaining long-term genome stability, consistent with
recent work27.
High p21 levels are required to inhibit CDK2 activity. Since
p21 is a CDK inhibitor, we sought to characterize how CDK2
activity changed in p21- versus p53-depleted cells. We generated
an hTert-RPE1 mRuby-PCNA cell line expressing a live cell
reporter of CDK2 activity28 and depleted p21 or p53 by siRNA. In
control siRNA-depleted cells, we see heterogeneity in CDK2
activity following mitosis (Fig. 2e) and there is signiﬁcant negative
correlation between the minimum level of CDK2 activity and G1
length (R¼  0.67**). In addition, 13.7% (7/51) of the population
enter a CDK2low state (red curves: CDK activityo0.75 a.u. at
600min, Fig. 2e), which, although arbitrarily deﬁned, is similar to
the percentage of cells entering a p21high state (red curves,
Fig. 1f). This suggests that the CDK2low state corresponds to the
p21high state and represents G1pm arrest before the RP. Indeed, if
we ﬁx unperturbed hTert-RPE1 cells co-expressing mRuby-
PCNA and the CDK2 activity sensor and immunostain for p21,
we see that CDK2low cells in G1 represent 16% of the population
and that these cells express high levels of p21 (Supplementary
Fig. 3h).
Consistent with p53 siRNA treatment in p21-GFP hTert-RPE1
cells, p53 depletion in CDK2 activity sensor expressing cells leads
to a more homogenous G1 length and cells do not enter G1pm
arrest (0/25; Fig. 2e). However, following p21 siRNA we still see
a strong negative correlation between the minimum CDK2
activity and G1 length (R¼  0.631**). We only observed one
p21-depleted cell entering a CDK2low state (1/68), suggesting that
the CDK2low G1pm arrest state is due to p21-dependent
inhibition of CDK activity, consistent with previous work22
(Fig. 2e). To determine how different levels of p21 correlate
with CDK2 activity, we imaged hTert-RPE1 p21-GFP cells
co-expressing an mRuby-tagged CDK2 activity sensor. We
found in cycling G1 cells that CDK2 activity is able to increase
in the presence of p21 protein (Fig. 2f, grey box). Moreover,
CDK2 activity remains high throughout G2 in unperturbed cells,
irrelevant of p21-GFP levels (Fig. 2f, brown box). Importantly, at
high p21-GFP levels in G1 cells, CDK2 activity is inhibited and
cells enter G1 arrest (Fig. 2g).
These data further support the notion that p53 signalling
induces p21 accumulation over G2M and G1D and, at sufﬁciently
high p21 levels in G1, CDK2 activity is inhibited leading to
a p21-dependent G1pm arrest. However, at low-intermediate
levels, p21 is a poor CDK2 inhibitor and a G1 delay is not
p21-dependent.
Basal p21 expression correlates with DNA damage foci. Given
our observation that p21 heterogeneity in unperturbed hTert-
RPE1 cells is p53-mediated, reﬂective of the time between S/G2 in
the mother and G1/S in the daughter, and that p21 starts to
increase in G2, we postulated that p21 levels increase in response
to endogenous DNA damage occurring during S-phase in the
mother cell. To assess this, we immunostained unperturbed
hTert-RPE1 cells with the DNA damage marker gH2AX and
noted a striking correlation between p21-GFP expression in
G1 and G2 cells and the presence of a single nuclear focus of
gH2AX (Fig. 3a–c). We found a similar correlation between foci
of 53BP1 and PS1981-ATM with p21-GFP levels (Supplementary
Figs 4a,b). These single foci represent endogenous DNA damage
(since no exogenous damaging agents were added) and resemble
stretches of incompletely replicated DNA29, leaving single-
stranded DNA (ssDNA) gaps in G2 cells. Indeed, in unpertur-
bed hTert-RPE1 cells we see colocalization of the ssDNA marker,
RPA2, with single gH2AX foci in G2, and an increase in both
RPA2 and gH2AX foci is seen after treatment with the DNA
polymerase inhibitor, aphidicolin (Supplementary Fig. 4c). Taken
together, we hypothesize that endogenous DNA damage
generated in unperturbed S-phases could trigger p21 expression
and be the molecular basis for the observed heterogeneity in
p21 levels.
To explore the link between endogenous DNA damage and
p21 expression, we generated hTert-RPE1 cells co-expressing
p21-GFP and mRuby-53BP1. 53BP1 localizes to DNA Double
Strand Breaks (DSBs) during G1 (ref. 30). Live cell imaging in
unperturbed cells revealed that DSBs co-segregate with p21-GFP
expression in G1 (Supplementary Movie 4; Supplementary
Fig. 4d). To determine how the presence of DNA damage foci
in G1 affects proliferation, we generated a cell line co-expressing
mRuby-PCNA and GFP-53BP1. Timelapse imaging revealed that
in the majority of cell divisions, sister G1 cells behave similarly
such that in 47% (67/142) of mitoses neither sister has a 53BP1
focus, in 24% (34/142) both sister cells have a focus, and in 29%
(41/142) only one sister has a focus (Fig. 3d). When both sister
cells have a 53BP1 focus, the timing of focus appearance shows
a small, but signiﬁcant, positive correlation (R¼ 0.39*; Fig. 3e).
Moreover, G1 cells displaying a 53BP1 focus have a longer
G1 phase than cells never displaying a focus (Fig. 3f). In 81%
(48/59) of G1 cells expressing GFP-53BP1 foci, foci start to
decrease in size before S-phase, suggesting that most hTert-RPE1
cells repair DNA damage prior to the G1/S transition. In
unperturbed mRuby-PCNA 53BP1-GFP expressing cells, 22%
(50/222) of cells enter a G1pm arrest, and of these, 82% (41/50)
have at least one 53BP1 focus, indicating a high correlation
between G1pm arrest and the presence of DNA damage.
These data suggest that DNA damage is inherited from
the mother cell leading to 53BP1 localization to DSBs in daughter
cells, that correlates with both a G1 delay and G1pm arrest.
Despite p21 levels correlating with the presence of 53BP1 foci
and a G1 delay, only G1pm arrest, but not G1 delay, is
p21-dependent.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14728 ARTICLE
NATURE COMMUNICATIONS | 8:14728 | DOI: 10.1038/ncomms14728 |www.nature.com/naturecommunications 5
Impaired DNA replication can induce p21 expression. Our data
suggest that stochastic DNA damage occurring during normal
DNA replication could generate the observed heterogeneity in
p21 expression. To determine if p21 expression can be induced by
impaired DNA replication during S-phase, we treated cells with
low dose aphidicolin. Aphidicolin treatment caused an increase in
the proportion of cells with a single gH2AX focus, in the number
of gH2AX foci per nucleus, and in p53 expression (Fig. 4a;
Supplementary Fig. 5a). In timelapse imaging of aphidicolin-
treated cells, we observed a longer S-phase, indicative of
replication fork slowing31, and a marked increase in p21-GFP
levels following S/G2, compared to DMSO-treated cells (Fig. 4b).
Following mitosis, 62.5% (20/32) of aphidicolin-treated cells
entered G1pm arrest, compared to 13.2% (5/38) of DMSO-treated
cells (Fig. 4b). In addition, 25% (8/32) of aphidicolin-treated cells
arrested in G2 with high p21-GFP expression, a phenotype rarely
observed in unperturbed cells. Of note, we observed that after
aphidicolin treatment of hTert-RPE1 cells expressing mRuby-
PCNA and a CDK2 activity sensor, that cells arresting in
G2 eventually downregulate CDK2 activity (Fig. 4d; top panel,
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yellow curves). This suggests that when levels of damaged DNA,
and corresponding p21 levels, exceed a threshold, CDK2 activity
is inhibited and cells undergo G2 arrest. Overall, these data show
that by inducing aberrant DNA replication with aphidicolin, cells
activate p21 expression, downstream of p53, which promotes
either a G1 or G2 arrest.
To further examine if DNA damage during S-phase can induce
p21 accumulation in G2, we treated cells with an ATR kinase
inhibitor (ATRi; AZD6738) to induce destablization of stalled
DNA replication forks32. Treatment with ATRi leads to an
increase in the proportion of cells with a single gH2AX focus, in
the number of gH2AX foci per nucleus, and in p53 expression
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(Fig. 4c; Supplementary Fig. 5b). Similar to aphidicolin treatment,
cells treated with ATRi display a marked increase in p21-GFP
levels in cells in G1, compared to DMSO-treated cells (Fig. 4b).
The number of cells arresting in G1 following mitosis
also increased from 13.2% (5/38) in DMSO-treated cells to
52.5% (21/40) in ATRi-treated cells (Fig. 4b). However, unlike
aphidicolin treatment, we saw a small, but signiﬁcant, decrease in
S-phase length when compared to DMSO-treated cells
(Supplementary Fig. 5c), and no cells were observed to arrest in
G2, consistent with G2 arrest being ATR-dependent33. Taken
together, these data demonstrate that in the absence of
ATR activity, DNA damage in S-phase leads to accumulation of
p21 protein that frequently exceeds the threshold required for
cell cycle arrest.
To determine if p21 and/or p53 is required for the cellular
response to impaired DNA replication, we depleted p21 or p53 by
siRNA and treated hTert-RPE1 cells expressing mRuby-PCNA
and the CDK2 activity sensor with aphidicolin. p53-depleted cells
treated with aphidicolin were unable to arrest in G1 (0/32)
(Fig. 4d), G1 length was more homogenous and G2 arrest was
absent. However, in a fraction of cells, an extended G2 phase was
observed. In p21-depleted cells treated with aphidicolin, there was
no G2 arrest (0/42; although similar to p53-depleted cells
extended G2 lengths were observed), and G1pm arrest was
severely compromised compared to control siRNA-treated cells
(7/42 p21-depleted cells arrest versus 17/24 in control siRNA-
depleted cells; Fig. 4d). These data support our conclusion that
G1pm arrest is p21- and p53-dependent, and also reveal a p53-
and p21-dependent G2 arrest.
Skp2 and Cdt2 degrade p21 with different rates and timings.
Since p21-GFP is absent in all cells during S-phase, we hypo-
thesized that, while high levels of p21 promote cell cycle arrest, its
removal is required for efﬁcient DNA replication. Both SCFSkp2
and CRL4Cdt2 have been implicated in p21 degradation at the
G1/S transition34–38 and we wanted to determine the relative
contribution of these two pathways to p21 removal.
Following Skp2 depletion by siRNA, we ﬁnd that p21-GFP is
still degraded prior to and over S-phase (Fig. 5a; Supplementary
Fig. 6a,b). However, p21-GFP degradation becomes switch-like
at the G1/S transition in Skp2-depleted cells (Fig. 5a). While
in control siRNA-depleted cells p21-GFP levels correlate with
G1 length (R¼ 0.76**), in Skp2-depleted cells G1 length was
longer and showed weaker correlation with p21-GFP levels
(R¼ 0.40**; Fig. 5b). These data suggest that SCFSkp2 plays an
important role in degrading p21 prior to the G1/S transition and
is responsible for the slower rate of p21 degradation during G1.
Additionally, in control siRNA-treated cells we observed a ‘burst’
in p21-GFP expression after mitosis. However, following SCFSkp2
depletion, p21-GFP levels in G2 increased much more rapidly
and no post-mitotic burst in p21-GFP was observed (Fig. 5a).
After Cdt2 depletion by siRNA, notably fewer cells entered
S-phase than control-depleted cells, and only cells that removed
p21-GFP to undetectable levels entered S-phase (Fig. 5a,b;
Supplementary Fig. 6c; Methods). In Cdt2-depleted cells,
p21-GFP levels increased immediately after S-phase entry
(Fig. 5a) and this increase was associated with a longer S-phase.
We observed anti-correlated cycles of p21-GFP expression with
mRuby-PCNA foci over short time frames—suggestive of
interrupted cycles of incomplete DNA replication
(Supplementary Fig. 6d; Supplementary Movie 5). Cell death
was also observed following Cdt2 depletion. Finally, switch-like
degradation of p21-GFP at the G1/S transition was abolished
when Cdt2 was depleted (Fig. 5a). Thus, our data show
that CRL4Cdt2 is essential for degrading p21 during S-phase
and is responsible for the switch-like, rapid degradation of p21 at
the G1/S transition. Cdt2 depletion phenotypes were rescued by
p21 and Cdt2 co-depletion—where cells had normal S-phase
lengths (Supplementary Fig. 6e), and no interrupted
DNA replication or cell death was observed. These data show
that even the presence of low levels of p21 during S-phase
can perturb DNA replication, cause premature S-phase exit,
and cell death.
Depleting both Skp2 and Cdt2 prevented the vast majority of
cells from entering S-phase (Fig. 5a). Cells that did enter S-phase
had p21-GFP levels below our detection limit (Fig. 5b). Of note,
we observed that after depletion of only Cdt2, or after Cdt2 and
Skp2 co-depletion, overall p21-GFP levels increased over time,
indicative of accumulating DNA damage (Fig. 5c). Thus we
ﬁnd that p21 removal at the G1/S transition promotes efﬁcient
DNA replication, limiting DNA damage, and that SCFSkp2
and CRL4Cdt2 cooperate to degrade p21 with different rates
and timings.
Two double-negative feedback loops control p21 degradation.
To understand the mechanism behind p21 dynamics and its
removal, we sought to mathematically model p21 regulation. We
constructed a wiring diagram based on well-established reactions
that make up the p21 control network (Fig. 6a; Methods). In our
model, two double-negative feedback loops control p21 expres-
sion: (i) phosphorylation by CDK2 targets p21 for Skp2-depen-
dent degradation24,39, while high levels of p21 inhibit CDK2
activity6; and (ii) PCNA in active replication complexes (aRCs)
recruits CRL4Cdt2 to degrade p21 (refs 24,40), while p21 can bind
to PCNA interfering with its function as a processivity factor
during DNA replication41,42.
Consistent with our data, stochastic simulations show
p21 degradation prior to the G1/S transition, the absence of
p21 during S-phase, and its re-accumulation in G2 (Fig. 6b;
Supplementary Fig. 7a). p21 loss in G1 is mainly caused by
increasing CDK2 activity, which promotes Skp2-dependent
degradation at a comparatively low rate. Once CDK2:Cyclins
reach a threshold, PCNA loading onto DNA is triggered, aRCs
accumulate, and strong Cdt2-dependent degradation removes
residual p21 while the cell enters S-phase. At the end of S-phase,
aRCs disappear and p21 re-accumulates. We also see signiﬁcant
intra- and inter-cellular variability in p21 levels due to the
stochasticity of DNA damage and p53, supporting our experi-
mental observations (Fig. 6c). However, p21 remains low over
S-phase even when damage occurs, consistent with data from
our experiments (Figs 2c,d and 4b). This is due to the presence
of a bistable switch, which creates two distinct cellular states
with either high or low p21 level depending on the cell cycle stage
(Fig. 6d). In G1, CDK2 activity is low and RCs are inactive such
that p21 is attracted to the upper steady state. As CDK2:Cyclin
accumulates and origins ﬁre, p21 is lost and cells enter S-phase.
The existence of a bistable region between both states allows the
S-phase level of p21 to be insensitive to DNA damage, while
damage in G1 (and G2, Supplementary Fig. 7b) leads to an
increase in p21 and in the CDK2:Cyclin threshold required to
enter S-phase. Hence, large amounts of damage can cause G1pm
arrest (Fig. 6d, topmost curve).
We sought to test the relative importance of the Skp2- and
Cdt2-degradation pathways for bistability. Skp2 depletion leaves
the bistable switch intact such that S-phase levels of p21 remain
low (Supplementary Fig. 7c). However, Skp2-depleted cells show
a more rapid p21 degradation prior to S-phase and a more rapid
re-accumulation in G2 (Fig. 6e, left panels). Cdt2 depletion
almost completely abolishes bistability, which makes the
G1/S transition easier to reverse (Supplementary Fig. 7c), and
leads to p21 expression during S-phase (Fig. 6e, right panels).
This latter phenotype is more pronounced in cells depleted of
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both Skp2 and Cdt2 (Supplementary Fig. 7d). As found
experimentally (Supplementary Fig. 6d,e), p21 expression during
S-phase can cause premature S-phase exit, which modelling
suggests is due to PCNA inhibition (Supplementary Fig. 7e).
Hence, strong Cdt2-dependent degradation of p21 ensures an
irreversible G1/S transition and undisturbed DNA replication.
In summary, we have developed a model that not only
explains p21 dynamics in unperturbed and DNA damaged
cells but also correctly predicts the effects of Skp2 and
Cdt2 depletion experiments. Moreover, modelling conﬁrms
that stochastic DNA damage events are a major source of inter-
and intra-cellular heterogeneity in p21 levels, and reveals a
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bistable switch that makes S-phase cells unable to accumulate
p21 protein.
Arrest in response to serum starvation is not p21-dependent.
Given that passage through the RP depends on mitogen-signal-
ling and thus serum concentration, we wanted to determine how
p21-GFP levels change in hTert-RPE1 cells during
G1pm arrest in response to serum starvation. As cells exit mitosis
in the absence of serum, the majority (90%; 26/29) enter G1pm
arrest (Fig. 7a). Importantly, these arresting cells have variable
p21-GFP levels, and many serum-starved G1pm-arrested cells
have low p21-GFP levels, comparable to those measured during
G1 in cycling cells (Fig. 1f). Moreover, unlike cells in serum,
G2M p21-GFP levels do not correlate with G1pm arrest
(R¼ 0.0989, P¼ 0.6098). Therefore, while G1pm arrest in the
presence of high serum is characterized by high p21 expression,
G1pm arrest after serum withdrawal is not.
Since we did not observe a correlation between p21-GFP levels
and G1pm arrest after serum starvation, we wanted to know if
cells could arrest in G1 in response to serum withdrawal in the
absence of p21 protein. We serum-starved WT, p21KO1 and
p21KO2 hTert-RPE1 cells and measured their cell cycle proﬁles
by FACS. We found that p21KO cells arrested in G1 as efﬁciently
as WT cells in response to serum withdrawal (Fig. 7b).
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This indicates that p21 is not required for G1pm arrest after
serum removal.
Thus there exist two molecularly distinct G1pm arrest states—
one that occurs in the presence of serum and is p21-dependent,
and another that occurs following serum withdrawal that is
p21 independent. Furthermore, the p53- and p21-dependent
G1pm arrest we observe in cells grown in high serum is
principally caused by endogenous DNA damage.
Discussion
In this study, we sought to characterize and understand the role of
p21 in regulating the proliferation-quiescence decision and genome
stability in unperturbed cells. In response to DNA damage
generated during S-phase, p21 accumulation begins in G2M and
continues into G1D, where, at sufﬁciently high levels, p21 inhibits
CDK activity and promotes G1 arrest following mitosis.
Our experiments demonstrate that in unperturbed cycling cells,
heterogeneity in p21 levels is fully accounted for by p53. This is
consistent with a recent report demonstrating that, in cells
expressing both p53-YFP and p21-CFP, p21-CFP levels peak
following peaks in p53-YFP (ref. 43). The authors also observed
a spike in p53 and p21 levels following mitosis, agreeing with
our observation that p21-GFP levels increase rapidly in G1 post-
mitosis. This may be explained in part by ssDNA breaks
generated by incomplete DNA replication in the mother cell
being converted to DSBs during mitosis44,45. A post-mitotic
increase in p21 levels can also be explained by SCFSkp2-mediated
p21 degradation being turned off in G1 by increasing APC/CCdh1
activity46,47. Since we observe signiﬁcantly higher levels of p21 in
G2, as well as a reduced p21 increase in G1, following Skp2
depletion, this suggests that the post-mitotic burst in p21 is likely
to be a combination of both SCFSkp2-inactivation and additional
DNA damage occurring over mitosis.
Spencer et al.22 demonstrated that p21 is responsible for
a bifurcation in CDK2 activity following mitosis, and that this
underpins the proliferation-quiescence decision in cycling cells.
We ﬁnd that the source of bifurcation in the p21-dependent
proliferation-quiescence decision is endogenous DNA damage
occurring in the mother cell (Fig. 7c). Strikingly, we ﬁnd that
while p21 is responsible for G1pm arrest, heterogeneity in
G1 length is not p21-dependent. Because heterogeneity in
G1 length is p53-dependent, this explains the correlation
between p21 levels and G1 phase length; p53 activity is leading
to transcriptional activation of p21, as well as causing a G1 delay.
Thus, p21 is acting as a readout of p53 activity, while having
an insigniﬁcant effect on G1 phase length. Determining the
mechanisms responsible for this p53-dependent G1 delay remains
an open challenge.
Our data and modelling suggest that p21 degradation has the
hallmarks of bistability due to two double-negative feedback loops
involving SCFSkp2 and CRL4Cdt2. Thus we provide experimental
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evidence for, and extend on, previous work which concluded that
the decision to remain quiescent or proliferate is bistable because
of feedback regulation between p21 and CDK2 via SCFSkp2
(ref. 21). Moreover, our ﬁnding that CRL4Cdt2 is required for
p21 degradation at the G1/S transition and over S-phase is
consistent with previous work by Kim et al. who ﬁnd, in line with
our experiments, that DNA re-replication occurs in the absence
of CRL4Cdt2 and that this is p21-dependent38.
We speculate that p21 acts downstream of pulsatile
p53 signalling to integrate information on DNA damage during
mother G2/M- and the daughter G1-phases that then determines
the outcome of the proliferation-quiescence decision in G1.
Complete degradation of p21 before S-phase entry would ensure
that information on DNA damage generated during the previous
cycle is fully erased before cells commit to a new cell cycle.
This would allow the process of gathering information on
DNA damage to begin anew following S/G2 passage. The
presence of an information-gathering phase and a reset phase
would allow cells to make a decision on whether to proliferate or
quiesce in response to DNA damage that remains consistent
across populations and generations of cells.
Methods
Cell culture. hTert-RPE1 cells were from ATCC and were maintained in DMEM
(Gibco)þ 10% FBS (Sigma) and 1% Penicillin-Streptomycin (P/S; Gibco) at 37 C
and 5% CO2. Cell lines were checked by PCR on a monthly basis for absence of
mycoplasma.
Generating mRuby-PCNA tagged hTert-RPE1 cell line. One allele of the
endogenous PCNA gene was tagged at the N-terminus with a cDNA encoding
the mRuby ﬂuorophore using AAV-directed homologous recombination.
To generate the targeting construct, Left and Right Homology Arms (LHA, RHA)
ﬂanking mRuby cDNA were ampliﬁed by PCR from hTert-RPE1 genomic
DNA using the following primers: P1 NotI: 50–cggccgcgaatcttcagttccctcaacaa-30
and P2: 50-ctttgatcaggctgtttgccatggtggcggagtggcaacaac-30 to amplify the
LHA including the ﬁrst 20 bp of mRuby; P3: 50-gttgttgccactccgccaccatggcaaacag
cctgatcaaag-30 including the ﬁrst 20 bp of PCNA LHA; and P4 XbaI: 50-ctcgaat
ctagatcctcctccccctccgcccaggccggc-30 to amplify mRuby and create a Gly-Gly-Gly-
Ser-Arg linker in front of the ﬁrst PCNA exon. P5 XbaI: 50-tctagattcgaggcg
cgcctggtc-30 and P6 NotI: 50-gcggccgcacggaggaggatcacttgagg-30 to generate the
RHA.
LHA and mRuby fragments were fused by PCR using P1 and P4 and cloned by
three-way ligation, together with the RHA into the NotI sites of pAAV-MCS
(Stratagene). The complete targeting construct was packed into pAAV viruses
using an AAV helper-free system (Stratagene), according to the manufacturer’s
instructions, followed by transduction of hTert-RPE1 cells. Four days after
transduction, single mRuby positive integrands were sorted by ﬂow cytometry into
96-well plates and analysed for correct targeting of PCNA by Western blotting.
Generating p21-GFP-tagged hTert-RPE1 cell lines. The endogenous CDKN1A
gene was tagged at the C-terminus using CRISPR-mediated gene tagging.
The gRNA 50-TTTGAGGCCCTCGCGCTTCCAGG-30 (PAM site in bold)
downstream of the CDKN1A stop codon was selected using crispr.mit.edu. Forward
and reverse oligos for the gRNA were annealed and ligated into the BbsI cut pX330
bicistronic Cas9 and sgRNA expression plasmid48. pX330-U6-Chimeric_BB-CBh-
hSpCas9 was a gift from Feng Zhang (Addgene plasmid # 42230).
For the homology donor plasmid, we PCR ampliﬁed CDKN1A homology
arms from hTert-RPE1 genomic DNA using the high-ﬁdelity Q5 DNA
polymerase (NEB). To PCR amplify the LHA we used the forward primer
with a NotI site: 50-gcggccgccaggccctttgccaagct-30 and the reverse primer with
a SalI site: 50-gtcgacgggcttcctcttggagaa-30 . To PCR amplify the RHA we used
the forward primer with a SpeI site 50- actagttccgcccacaggaagcctgcagttctgg-30
(underlined base represents mutated base to change the PAM site in the
recombined gene) and the reverse primer with a NotI site: 50-gcggccgc
atacccctaacacagagataaccccact-30 . GFP cDNA was PCR ampliﬁed from peGFP-C1
vector (Clontech) with the forward primer with a SalI site and a poly-glycine linker:
50-gtcgacggaggaggagtgagcaagggcgaggag-30 and the reverse primer with a SpeI site:
50-actagtttacttgtacagctcgtc-30 . 2LHA, RHA and eGFP PCR products were ligated
into the blunt-end cloning vector pJet1.2 (Fermentas) for restriction digest.
LHA, RHA and eGFP digested inserts were ligated into NotI cut pAAV-MCS
vector by 4-way ligation at a ratio of vector:inserts of 1:2:2:2, using T4 DNA ligase
(NEB). All constructs were checked by sequencing before transfection into cells.
To generate endogenously tagged p21-GFP cells, the pX330 p21 gRNA plasmid
and the p21 homology donor plasmid were transfected into hTert-RPE1 cells
at a ratio of 1:1 using Lipofectamine 2000, according to the manufacturer’s
instructions (Invitrogen). Cells were allowed to expand for 7 days before FACS
sorting to select GFP positive cells. Individual GFP expressing cells were sorted into
96-well plates containing 50:50 conditioned:fresh growth media. Clones were left to
expand for 10–14 days and then visualized on the Opera high-throughput
microscope (PerkinElmer) to determine which clones had GFP expression in the
nucleus. Candidate clones were expanded and further validated, as described in
Supplementary Fig. 1.
Western blotting. Samples were directly lysed by addition of Laemmli buffer.
Whole cell lysates were loaded onto 4–20% Tris-Glycine Novex precast gels
(ThermoFisher) followed by transfer to PVDF membranes. After protein transfer,
membranes were brieﬂy washed in MeOH and then dried between sheets of ﬁlter
paper. When completely dry, primary antibody diluted in 5% milk in TBS was
added and membranes were incubated overnight at 4 C with rocking. Membranes
were washed three times in TBSþ 0.05%TritonX-100 (TBS/T) and anti-mouse or
anti-rabbit HRP-conjugated secondary antibodies (CST) were diluted 1:2,000 in
5% milk in TBS and incubated with membranes for 1 h at RT, with rocking.
Membranes were washed three times in TBS/T and visualized using Pierce
ECL Western Blotting Substrate (ThermoScientiﬁc). All blots were scanned on the
Azure c300 imaging system.
Antibodies used in this study for Western blotting are p21 (BD, ms, 556430,
1:1,000), Skp2 (Proteintech 15010-1-AP, 1:500), Cdt2 (Bethyl A300-948A, 1:250),
p53 (CST 2527, 1:2,000) and GAPDH (Novus NB300-221, 1:5,000).
Coimmunoprecipitation. To determine if p21-GFP could bind to CDK2,
we performed immunoprecipitation of GFP-tagged p21 using the mMACS
GFP Isolation kit (Miltenyi). Immunoprecipitations were performed simulta-
neously from asynchronous mRuby-PCNA hTert-RPE1 cells and p21-GFP
mRuby-PCNA hTert-RPE1 cells, according to the manufacturer’s instructions.
mRuby-PCNA hTert-RPE1 cells served as a negative control since they do not
express GFP. Eluted samples were separated by SDS-PAGE, transferred to PVDF
and probed with anti-p21 and anti-CDK2 antibodies.
Growth curves. Cells were plated at a density of 50,000 cells per well in 6-well
plates. Duplicate cell counts were taken every 24 h using the Countess cell counter
(Invitrogen).
Generating p21KO cell lines. We generated two CDKN1A nickase targeting
vectors, based on the methods described in ref. 49. For p21KO1, we used the two
gRNA sequences: 50-CCATTAGCGCATCACAGTCG-30 and 50-TCCAGGAGGC
CCGTGAGCGA-30 . For p21 KO2, we used the two gRNA sequences: 50-TCAGCT
GCTCGCTGTCCACT-30 and 50-CCGCGACTGTGATGCGCTAA-30. These
were annealed and ligated into the dual sgRNA All-in-One Cas9D10A GFP nickase
vector49. After sequencing, plasmids were transfected into hTert-RPE1 cells
expressing mRuby-PCNA. Three days post transfection, GFP positive cells
were sorted to single-cell density into three 96-well plates containing 1:1
conditioned:fresh growth media. Clones were left to expand for 7–10 days
and then screened for p21 expression by immunostaining. Clones deemed
to be negative based on p21 immunostaining were characterized further by
genotyping.
For genotyping of p21KO lines, genomic DNA was extracted using the
Flexigene DNA kit, according to the manufacturer’s instructions. The p21 gene was
ampliﬁed using nested PCR and primers: CDKN1A_KO_FWD1 50-ATGTCAG
AACCGGCT-30 and CDKN1A_KO_REV1 50-TTAGGGCTTCCTCTT-30 ,
followed by CDKN1A_KO_FWD2 50-GGATGTCCGTCAGAACCCAT and
CDKN1A_KO_REV2 50-GTGGGAAGGTAGAGCTTGGG-30 . The resultant
PCR product was ligated into the pJet1.2/blunt Cloning Vector (Fermentas).
Plasmid DNA was puriﬁed from individual colonies using the Qiagen Miniprep
kit and sent for sequencing using the pJet_forward primer. The results of the
genotyping are shown in Supplementary Note 1. Note that for p21KO1A,
10/10 colonies showed the same genotype suggesting that both alleles have the
same deletion.
Live cell imaging. Live cell imaging was performed on the Opera HC spinning
disk confocal microscope (PerkinElmer), with atmospheric control to maintain
cells at 37 C, 5% CO2 and 80% humidity. Cells were plated on 384 well CellCarrier
(PerkinElmer) plates at a density of 1,000 cells/well 24 h prior to imaging. Cells
were imaged using a 20X (N.A. 0.45) objective at 10min intervals for 24–72 h in
Phenol-Red Free DMEMþ 10% FBS and 1% P/S. Image processing was performed
in Matlab using custom-made scripts.
Testing 488nm exposures for live imaging. Since laser irradiation can induce
DNA damage, and thus p21 expression, we wanted to be sure that our imaging
conditions were not inducing p21 expression. Therefore, we imaged hTert-RPE1
mRuby-PCNA p21-GFP expressing cells using two 488 nm laser exposures where
the laser power was greater than the 20% used in our other experiments; exposure
time remained constant (120ms). The results are shown in Fig. 1d. Exposure
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1¼ 20%, Exposure 2¼ 30%, Exposure 3¼ 40% of 488 nm laser power. Across these
three different exposures, we saw no difference in cell cycle timing or amount of
p21-GFP expressed. Moreover, a two-sample Kolmogorov–Smirnov test produced
the null result indicating both samples came from the same continuous distribution
for both maximum G1 p21 after correction for 1.5X and 2X exposure difference:
20% versus 30% P¼ 0.938 and 20% versus 40% P¼ 0.243; and G1 length with
no correction: 20% versus 30% P¼ 0.916 and 20% versus 40% P¼ 0.607.
Inhibitors. Inhibitors used were ATRi (AZD6738; Selleckchem), Aphidicolin
(Sigma), Camptothecin (Sigma), Etoposide (Sigma) and Nutlin-3 (Sigma). All
drugs were reconstituted in DMSO and stored in aliquots at  20 C.
siRNA transfection. For live cell imaging, cells were either transfected 24 h prior
to imaging, or, in cases where we wanted to capture the ﬁrst cell cycle after protein
loss, 6 h prior to imaging. Cells were transfected with 20 nM ﬁnal concentration of
siRNA using Lipofectamine RNAiMax, according to the manufacturer’s protocol
(Invitrogen). Brieﬂy, per well of a 384 well plate, 40 nl of Lipofectamine RNAiMAX
was mixed with siRNA in 10ml OPTIMEM. To this, 20ml cells in media, at
a density of 5 104 cellsml 1 was added, and cells were incubated at 37 C.
siRNAs used in this study were OnTARGETplus pools (Dharmacon).
Cloning 53BP1-mRuby. GFP-53BP1 plasmid was a generous gift from Jiri Lukas50.
This plasmid contains full-length mouse 53BP1 cDNA tagged with GFP.
To visualize endogenously tagged p21-GFP and 53BP1 in the same cell line, we
changed the GFP tag for an mRuby tag in the 53BP1 plasmid. We removed
the GFP tag with BmtI and BspEI double digestion. We PCR ampliﬁed mRuby
with following primers: forward 50-gctagcatgaacagcctgatcaa-30 and reverse
50-tccggaccctccgcccaggccggcga-30 . Digested mRuby PCR product was ligated into
the cut 53BP1 vector and sequenced to check for in-frame ligation.
Generating GFP- and mRuby-53BP1 stable cell lines. hTert-RPE1 cells were
plated in six well plates to ensure a density of 80% conﬂuency on the day of
transfection. Cells were transfected with 4 g of plasmid using Lipofectamine 2000,
according to the manufacturer’s instructions (Invitrogen). After 24 h incubation,
cells were transferred to a T-25, and after a further 24 h, cells were sorted to single-
cell density in 96-well plates containing 50% fresh media:50% conditioned media
with 0.25mgml 1 G418 (Sigma), using the BD FACS Aria. After 10–14 days
selection, single-cell clones were visualized for appropriate expression of 53BP1 and
those clones were expanded.
Immunostaining. Cells were ﬁxed in an equal volume of media to warm
8% formaldehyde in PBS for 5min at 37 C. Cells were permeabilized in PBS/0.2%
TritonX-100 for 5min at RT and then blocked in 2% BSA in PBS (Blocking buffer)
for 1 h at RT. Cells were incubated in primary antibody diluted in Blocking buffer
for either 2 h at RT or overnight at 4 C. Cells were washed three times in PBS and
then incubated with Alexa-conjugated secondary antibodies (ThermoFisher)
diluted in Blocking Buffer for 1 h at RT. Cells were washed three times in PBS and
incubated in 1 mgml 1 Hoescht 33258 (Sigma) diluted in PBS for 15min at RT.
Cells were imaged on the Opera HC spinning disk confocal microscope
(PerkinElmer). All imaging data was uploaded to the Columbus image analysis
database (PerkinElmer) for visualization and analysis.
For RPA2 immunostaining, cells were plated onto glass coverslips. Cells were
brieﬂy washed in PBS and then pre-extracted using ice-cold PBS/0.2% TritonX-100
for 1min. Cells were then ﬁxed in warm 4% formaldehyde and processed as usual.
Cells on coverslips were imaged on a Zeiss LSM710 confocal microscope using
a 60x oil, N.A. 1.4 objective.
Primary antibodies used for immunostaining in this study are: p21 (BD 556430,
1:1,000), p53 (CST 2527, 1:1,000), 53BP1 (CST 4927, 1:1,000), gH2AX (CST 9718,
1:2,000), P-S1981-ATM (CST 4526, 1:500), RPA2 (Abcam ab2175, 1:250).
Automated image analysis of ﬁxed cells. All quantitative image analysis on ﬁxed
cells was performed using Columbus software (PerkinElmer). Individual protocols
are described below.
Measuring nuclear intensities of proteins. Nuclei were segmented based on
Hoescht intensity. Nuclei at the edge of the image and nucleio100 mm2 were
excluded. Mitotic nuclei were also excluded by excluding nuclei with Hoescht
intensity above a deﬁned threshold (that was deﬁned individually for each
experiment based on Hoescht staining intensity and imaging conditions). The
ﬂuorescence intensity of individual proteins was then calculated in each interphase
nucleus.
Measuring cytoplasmic intensities of proteins. Nuclei were segmented as above. To
measure cytoplasmic intensities of proteins, we deﬁned a cytoplasmic nuclear ring
region of four pixels beyond the nucleus. This was to exclude any effect cell shape or
area may have on cytoplasmic intensity readings. The cytoplasmic ﬂuorescence
intensity of individual proteins was then calculated in each ring region.
Counting nuclear foci. Nuclei were deﬁned as above. To deﬁne and count
gH2AX foci within nuclei, we needed to distinguish between the bright, individual
foci observed in G1 and G2 cells, from the dim, multiple gH2AX foci observed in
most S-phase cells. We segmented foci using the ‘Find Spots’ function in
Columbus. Speciﬁcally, we used Method A and deﬁned the Relative Spot Intensity
as 0.290 and the Splitting Coefﬁcient as 1. We validated our automated focus
ﬁnding against manual scoring of foci.
Excluding S-phase cells. When scoring p21-GFP levels and foci in cells, we wanted
to exclude S-phase cells from the analysis since p21 levels are negligible in all S-phase
cells. To exclude S-phase cells, we used a Linear Classiﬁer in Columbus. Inputs to the
Linear Classiﬁer were a combination of Nuclear Morphology (Area, Roundness,
Width, Length, Ratio Width to Length), Hoescht Texture Properties (SER Features),
PCNA Intensity Properties, and PCNA Texture Properties (SER Features).
Automated cell tracking. Live imaging data was analysed using custom image
analysis scripts (see below and Supplementary Software 1). The exception to this
was analysis of hTert-RPE1 mRuby-PCNA cells expressing GFP-53BP1, which
were manually analysed using Volocity software (PerkinElmer) as we were unable
to achieve reliable tracking of 53BP1 foci, and hTert-RPE1 p21-GFP cells expres-
sing CDK2L-mRuby (CDK2 sensor28) since there was no constant nuclear signal to
track reliably.
For automated tracking of hTert-RPE1 cells expressing ﬂuorescent markers
in higher throughput we developed a cell-tracking pipeline in the commercial
scripting language Matlab. The pipeline tracks cells and extracts data from
sequences of uncompressed TIF images, captured from live cell imaging.
Segmentation is based on well-established methods, while tracking is an
implementation of a probabilistic tracking algorithm deﬁned in refs 51,52.
The code for cell tracking can be found online and contains an example
(cellcycle.org.uk; Resources). The key steps in this pipeline are outlined below:
1. Nuclear segmentation:
1. Initial background correction is performed on individual images; here
a highly blurred image (very wide Gaussian kernel) is negated from the
original image.
2. Images from channels with a nuclear probe are combined to maximize the
quality of nuclear segmentation, this principally involves channels contain-
ing the p21-GFP and mRuby-PCNA signal.
3. Nuclei are subsequently segmented from the ﬁltered, combined, image using
Marker Controlled Watershed Segmentation.
4. Segments with intensity or size below a threshold are ﬁltered out, as these
correspond to mis-segmented background noise.
5. Segmented images are saved as equally sized zero matrices with each nuclei
region uniquely labelled.
2. Feature extraction: features describing morphology and ﬂuorescent marker
levels and localization for each channel are obtained for each segmented object
in each frame. Importantly, here we extract intensity and texture features from
unﬁltered images. The reasoning behind this is being that across the
experiments we perform, average intensity levels can vary over several orders
of magnitude for example, under Nutlin-3 treatment; plate-wise or well-wise
ﬁltering here can mask true levels of p21 relative to controls. Speciﬁcally the
features we extract are:
1. Cell area: area in pixels of the segmented nuclei
2. Major axis length: length of the ellipse that is equivalent based on second
order moments to the segment53
3. Minor axis length: width of the ellipse that is equivalent based on second
order moments to the segment53
4. Eccentricity: eccentricity of the ellipse that is equivalent based on second
order moments to the segment53
5. Equivalent diameter: diameter of the circle with the same area as the segment
6. Solidity: percentage of pixels in the convex hull surrounding the segment
which are also in the segment
7. Perimeter: perimeter length of the segment
8. Roundness: deﬁned as 4p area/perimeter2 (ref. 53)
9. PCNA mean intensity
10. s.d. of PCNA intensity
11. Kurtosis of PCNA intensity
12. Foci strength: PCNA intensities below the mean are removed, the s.d. of
pixels above the mean is then calculated. This identiﬁes bright spots, and
ignores dark spots in the nucleus, for example, nucleoli.
13. p21 mean intensity
14. p21 s.d.
15. Mean silhouette score: K-mean clustering (K¼ 2) is performed on nuclei
segments, and the mean silhouette score of the two clusters calculated. This
feature identiﬁes dumbbell shapes and is indicative of double nuclei
segments.These features are deﬁned in the single-cell track matrices
presented online. In these matrices the ﬁrst column gives cell index, the
second time point and third migration distance. Subsequent columns are
features as deﬁned above.For CDK2 activity data, p21 intensities are
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replaced with CDK2L-GFP nuclear intensity, CDK2L-GFP ring region
intensity, and the ratio of these two values. The ring region, here deﬁned as
a seven pixel wide ring surrounding the nucleus, has been shown to
perform effectively in measuring nuclear translocation54.
3. Segment probability: segments can be one of ﬁve deﬁned objects, either
correctly segmented (one nucleus, mitotic nucleus, nucleus exiting mitosis) or
incorrectly segmented (no nuclei, more than one nuclei). Probabilistic tracking
maximizes the likelihood that a track corresponds to the movements and
divisions of a single nucleus. Thus for tracking, probabilities are assigned to
each of the ﬁve possibilities mentioned, for each segment, in each frame such
that tracking can maximize the likelihood a single nucleus is followed. This is
performed by manually selecting examples of each of the deﬁned objects, for
example, mitotic nuclei, or multiple nuclei, from all segmented objects within
a graphical user interface (GUI). Subsequently, a support vector machine
classiﬁer is trained on these manually selected examples. The classiﬁer is used
to assign a probability to every segment, in every frame, of it being one of these
objects. As such, every segmented object, in every frame, is assigned ﬁve
posterior probabilities corresponding to the likelihood of it being: one nucleus;
mitotic nucleus; nucleus exiting mitosis; no nuclei; more than one nuclei.
4. Probabilistic tracking: The goal of automated cell tracking is to generate a set of
tracks that correspond to individual nuclei as they move across the ﬁeld of view
(FOV), and to capture cell division events, such that the lineage of nuclei is
recorded. Brieﬂy, in the automated probabilistic tracking algorithm used51,
hill-climbing optimization is performed to maximize a cost function designed
to meet the goal set out above. Speciﬁcally the cost function penalizes large
movements, and rewards tracks which follow segments that have a high
probability of being a single cell; or an object with a high probability of being
mitotic where in subsequent frames two objects exist that have a high
probability of being mitotic exit cells. Optimization is performed by iteratively
adding the highest scoring track, from the set of all possible new tracks, given
the current set of tracks. To ﬁnd the highest scoring track, given the current set
of tracks, a dynamic programming technique is used. Notably, the algorithm
can handle gaps and nuclei entering and exiting the FOV51.
5. Manual correction: automated tracking performs the majority of work in
tracking the hTERT-RPE1 cells, however these cells are highly motile, and
some of the conditions we use increase motility even further. As a result, the
error rate in tracking ranges from 1 mistake, per cell, per 300 frames; to
1 mistake, per cell, per 20 frames. In the cell cycle analysis we are performing it
is essential we obtain near 100% accuracy. As such, we developed a GUI to
efﬁciently amend errors in automated tracking, as well as compare the feature
values of tracked cells against the original confocal microscopy images. This
allows us to achieve nearly 100% accuracy in tracking, and more importantly if
we identify outliers, or unexpected results in later analysis we can return to the
videos and visually inspect whether the result is genuine or the product of
a tracking error.
Deﬁning G1/S and S/G2 transitions. We deﬁne G1/S transition as the point at
which both mRuby-PCNA intensity begins to increase and we see the appearance
of textured PCNA in the nucleus. This is characterized by a small jump in the
PCNA foci strength feature (Fig. 1b; Supplementary Fig. 2g). As further evidence
this is in fact the G1/S transition, we utilized hTERT-RPE1 cells expressing both
mRuby-PCNA and endogenously tagged CyclinA2-mVenus. Single-cell traces of
this dual expressing line showed us at a single-cell level CyclinA2-mVenus intensity
increases at exactly the same time as mRuby-PCNA intensity, providing further
evidence this is the G1/S transition (Supplementary Fig. 2g).
We deﬁne the S/G2 transition as the point at which mRuby-PCNA foci are
at their maximum strength (Fig. 1a); after this we see rapid disassembly of foci
and homogenous PCNA levels across the nucleus. This deﬁnition is consistent
with previous studies looking at nuclear PCNA dynamics55. Quantitatively, this
time point is characterized by the peak of a sharp spike in the PCNA foci strength
measure; this sharp spike being exhibited by all cells undergoing S-phase. At
this time point we also see p21-GFP levels switch on in all cells that express
p21-GFP in G2.
Mitosis was deﬁned by gross morphology changes, principally this is seen
as a spike in cell area lasting for one or two frames, corresponding to nuclear
envelope breakdown, followed by the nuclear area becoming signiﬁcantly smaller
(Fig. 1b). All transitions were manually marked on cell tracks, for further analysis
and computational synchronization of tracks, using a GUI tool developed in
Matlab. Single-cell tracks and manually labelled time points for each ﬁgure are
provided online as Matlab matrices, with scripts to visualize time point positions.
Sampling cell tracks for ﬁgures and normalization. To determine correlations,
between p21 levels and phase length, for both control data and depletion
experiments, a single-cell lineage was used. This was selected based on the daughter
cell captured within the FOV for the longest period of time. The likelihood of arrest
observed using this sampling regime very closely matched (21% n¼ 47/219) that
observed for sampling both daughters, where only mitosis in which both daughters
are subsequently tracked for greater than 60 frames are used (23% n¼ 29/128).
The single lineage-sampling regime is used outside of calculations comparing
daughters, as here n is greater. In all conditions at least two technical replicates
were analysed, and tracks from each replicate were visually compared to ensure
dynamics were consistent, prior to pooling of the data.
Relative p21 levels decreased over imaging, this is due to intensity adjustments
made by the microscope, due to increasingly bright images, (more p21-GFP
expressing cells). No adjustment for this decrease was made, such that data remains
faithful to the original imaging data sets, though baseline levels for arrest thresholds
are deﬁned at 15 a.u.
For all p21-GFP traces except Fig. 1b, p21-GFP levels were normalized using
the lowest level of p21-GFP captured across all tracks. This value (4 a.u. for
Fig. 1c traces) was generally similar to those seen in imaging (p21-GFP background
levels were 12 a.u. In the ﬁrst frame at the 10th percentile, while p21-GFP
background levels were 2 a.u. in the last frame at the 10th percentile). The lowest
track level was used rather than imaging baseline values, to avoid negative values.
Maximum and mean p21 expression levels and P-values. p21-GFP values, used
for population mean, s.d. and correlation measures in the main text are derived
from the maximum p21-GFP value reached within a single cell in the cell cycle
phase deﬁned. The maximum p21-GFP value was used rather than the mean
p21 value, as this generally gave stronger correlations to cell cycle phase length,
though in all cases analysed for both mean and maximum the mean value also
provided a statistically signiﬁcant correlation.
While both maximum G1 p21 levels and G1 length were not normally
distributed as determined by a one sample Kolmogorov–Smirnov test
(G1 p21 levels, P¼ 1.8677e-04; G1 length, P¼ 0.0012). Following log
transformation, the sample fell under the normal distribution (G1 p21 levels,
P¼ 0.1467; G1 length, P¼ 0.2408). Therefore, we calculated the Pearson
correlations on the log-transformed data as well, since Pearson’s correlation does
not fully describe the association of data which does not fall under a bivariate
normal distribution. While correlation values did change, at no point did
a previously signiﬁcant result become insigniﬁcant. As such, for simplicity and to
match that data presented in ﬁgures, correlations determined on the
untransformed data are given in the main text.
Supplementary Table 1 gives the values quoted in the main text (derived from
the maximum p21 value per cell, per phase) alongside the respected value derived
from the mean p21 level per cell. Full P-values are also quoted in this table;
otherwise Po0.01 is marked by **, and Po0.05 is denoted by *. Correlations
between p21-GFP levels (mean and maximum) with phase lengths following
S-phase are also quoted. Results following log transformation of the max p21 levels
versus length data are also given.
Mitotic timing masks correlation between G2M and G1D lengths. Given that we
observe strong correlation between i) p21-GFP levels in the mother G2 (G2M) and
daughter G1 (G1D), ii) p21-GFP levels in G2M and G2M length, and iii) p21-GFP
levels in G1D and G1D length; we were initially surprised to ﬁnd no correlation
between G2M length and G1D length. However, in this comparison noise in the
timing of mitosis has the dual effect of increasing G2M length and decreasing
G1D length, and vice versa. Thus, if noise in mitotic timing is indeed masking the
relationship between cell cycle phase length and p21 levels, we reasoned that
the combined length of G2M and G1D would correlate better with the maximum
p21-level reached than either length alone. We found this to be the case with
R¼ 0.68** for maximum p21 level in G2M/G1D against length of G2M/G1D, versus
against length of G1D (R¼ 0.62**) or G2M (R¼ 0.52**) alone. This result was
calculated from the merged experimental repeats (n¼ 4). Within each repeat this
result held as well (see Supplementary Table 2).
Nutlin-3 leads to rate dependent G2 arrest. In cells exiting S-phase following
Nutlin-3 treatment we observed a G2 arrest that was dependent on the rate of
p21 accumulation, meaning, those cells with the fastest rate of p21-GFP
accumulation (m¼ 0.25 a.u. per min) at the end of S-phase arrested in G2, while
those displaying a slower rate of p21-GFP accumulation (m¼ 0.1 a.u. per min)
underwent mitosis and arrested in the following G1 (Fig. 2d). Furthermore, the
rate of p21 increase between 100 and 200min following S/G2 correlated with
arrest (R¼ 0.46**). Thus G2 arrest appears to be dependent on the rate of
p21 accumulation following S/G2 transition. Finally, we note that those cells that
were earlier in S-phase at the time of Nutlin-3 addition, are more likely to arrest
compared to those exiting S-phase sooner, this is evident from correlation observed
between S/G2 transition time and whether a cell undergoes G2 arrest or not
(R¼ 0.34*). We suggest that this is due to accumulated p53 stabilization over
S-phase. This means that the longer a cell is in S-phase in the presence of Nutlin-3,
more p53 is stabilized and more p21 mRNA accumulates. Thus when a cell exits
S-phase and p21 degradation is switched off, p21 protein accumulates faster,
increasing the likelihood of G2 arrest.
S-phase entry is compromised following Cdt2 depletion. Following Cdt2
depletion, or Cdt2 and Skp2 co-depletion, we observed signiﬁcantly fewer cells
entering S-phase. For each FOV we counted the number of traces obtained in
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which cells are captured for an entire S-phase, and periods of 100min before and
200min after (as plotted in Fig. 5a). We found the average number of traces per
FOV to be 32.5 for control siRNA, 27 for Skp2 siRNA, 12.3 for Cdt2 siRNA, and
6.3 for Cdt2 and Skp2 co-depletion.
Mathematical modelling. Based on the wiring diagram in Fig. 6a, we derived
a set of nonlinear ordinary differential equations to describe the rate of change of
components in the p21 control network over time (see Supplementary Software 2).
Reaction kinetics were chosen according to the law of mass action with a few
exceptions listed below.
Protein transcription and translation: Part of the noise in cell cycle progression
stems from the low copy numbers of mRNAs that encode for regulatory proteins56.
To account for this, we modelled the level of mRNAs of p21 (mRNAp21), cyclins
(mRNACy), and p53 (mRNAp53).
dmRNAp21
dt
¼ kSymRNA þ kSymRNA;p53  p53 kDemRNA mRNAp21; ð1Þ
dmRNACy
dt
¼ kSymRNA  kDemRNA mRNACy; ð2Þ
dmRNAp53
dt
¼ kSymRNA  kDemRNA mRNAp53; ð3Þ
where mRNAs are synthesized and degraded with the constitutive rates kSymRNA and
kDemRNA, respectively, and k
Sy
mRNA;p53 denotes the rate of p53-dependent synthesis of
p21 mRNAs. Here and in the rest of the model we assumed that cyclin corresponds
to the sum of CyclinE and CyclinA, which both activate CDK2. p21 (p21), cyclins
(Cy) and p53 (p53) are produced from their mRNAs according to the following
equations.
dp21t
dt
¼ kSyp21 mRNAp21  rDep21  p21t; ð4Þ
dCyt
dt
¼ kSyCy mRNACy  rDeCy  Cyt; ð5Þ
dp53
dt
¼ kSyp53 mRNAp53  rDep53  p53; ð6Þ
with kSyp21, k
Sy
Cy and k
Sy
p53 denoting the protein synthesis rates, and r
De
p21, r
De
Cy and
rDep53 the corresponding degradation rates. The subscript t indicates total protein
levels, which include the protein in its free from and as part of larger complexes.
Also note that since CDK2 is in excess over its cyclins57, Cyt corresponds directly to
the total level of CDK2:Cyclin complexes with Cy denoting the level of active
CDK2:Cyclin. Protein degradation rates are as follows.
rDeCy ¼ kDeCy þ kDeCy;Cy  Skp2  Cy; ð7Þ
rDep21 ¼ kDep21 þ kDep21;Cy  Skp2  Cyþ kDep21;RCa  Cdt2  RCa; ð8Þ
rDep53 ¼
kDep53
jp53 þDam : ð9Þ
The constitutive rates of cyclin and p21 degradation are kDeCy and k
De
p21, respectively.
In addition, CDK2-mediated phosphorylation can promote cyclin degradation
with rate kDeCy;Cy in an Skp2-dependent manner
58–60. Here, Skp2 denotes the relative
level of the SCFSkp2 ubiquitin ligase. Similarly, p21 degradation occurs with
rate kDep21;Cy through a pathway involving CDK2 phosphorylation and Skp2
(refs 24,59), but also with rate kDep21;RCavia CRL4
Cdt2 (Cdt2), which is recruited to
chromatin-bound PCNA24,40 within aRCs (RCa). For p53, stabilization has been
shown to occur in response to DNA damage61, which we accounted for by
assuming that p53 degradation with rate kDep53 is inversely proportional to the sum
of DNA damage (Dam) and an inhibition constant jp53.
CDK2 inhibition. At high levels, p21 can act as an efﬁcient inhibitor of CDK2
(ref. 6). Hence, we assumed that p21 binds to CDK2:Cyclin complexes converting
them from an active form (Cy) into an inactive one (CyP21).
dCyP21
dt
¼ kAsCyP21  p21  Cy kDsCyP21 þ rDep21 þ rDeCy
 
CyP21; ð10Þ
with Cy ¼ Cyt CyP21; ð11Þ
where kAsCeP21 and k
Ds
CeP21 denote the association and dissociation rate constants,
respectively, and the conservation equation (11) holds.
S-phase entry and DNA synthesis: Licensing of replication origins occurs
during late mitosis or early G1-phase resulting in the formation of pre-replication
complexes62. In our model, CDK2 activates these pre-replication complexes (RC)
converting them into replication complexes that are primed for PCNA loading
(RCp).
dRC
dt
¼  rPhRc  RCþ kDpRc  RCp  rDsRc  RC ð12Þ
with rPhRc ¼ kPhRc
Cyn
jnCy þCyn
: ð13Þ
Here, priming occurs by CDK2 phosphorylation with rate kPhRc in an ultrasensitive
fashion with Hill coefﬁcient n at a CDK2:Cyclin threshold of jCy. Primed
replication complexes can revert back to an unprimed state with a small rate kDpRc
and replication complexes are disassembled upon completion of S-phase with rate
rDsRc (see below). Once primed, replication complexes can bind free PCNA (PCNAa)
or PCNA with a p21 molecule bound to its PIP-box (PCNAi) forming either active
(RCa) or inactive (RCi) replication complexes, respectively.
dRCp
dt
¼ rPhRc  RC kDpRc  RCp  kAsRcPc
 PCNAa þPCNAið ÞRCp þ kDsRcPc RCa þRCið Þ rDsRc  RCp; ð14Þ
dRCa
dt
¼  kAsPcP21  p21  RCa þ kDsPcP21 þ rDeP21
 
RCi þ kAsRcPc  PCNAa
 RCp  kDsRcPc  RCa  rDsRc  RCa; ð15Þ
dRCi
dt
¼ kAsPcP21  p21  RCa  kDsPcP21 þ rDeP21
 
RCi þ kAsRcPc  PCNAi
 RCp  kDsRcPc  RCi  rDsRc  RCi; ð16Þ
where kAsRcPc and k
Ds
RcPc correspond to the rates of PCNA loading and unloading,
respectively. Note that p21 is the strongest known binding partner of PCNA63 and
it was proposed that it competes with other PCNA-binding proteins such as
processivity factors of DNA synthesis42,64. Thus, we assumed that binding of p21 to
aRCs with rate kAsPcP21 (or binding of PCNA:p21 complexes to RCp) creates
inaRCs65,66. Dissociation of p21 from PCNA in these complexes occurs with rate
kDsPcP21. In our model, aRCs synthesize DNA (DNA) and once DNA replication is
ﬁnished, replication complexes disassemble with rate rDsRc .
dDNA
dt
¼ kSyDna  RCa; ð17Þ
rDsRc ¼ H DNA 1ð Þ: ð18Þ
Here, kSyDna is the DNA synthesis rate and H the Heaviside function.
PCNA dynamics: We assumed that free PCNA in the nucleus (PCNAa) is
replenished from a cytoplasmic pool and that p21 can bind to PCNA creating
PCNA:p21 complexes (PCNAi).
dPCNAa
dt
¼ kImPc  kAsPcP21  p21  PCNAa þ kDsPcP21 þ rDep21
 
PCNAi
 kExPc þ kAsRcPcRCp
 
PCNAa þ kDsRcPc þ rDsRc
 
RCa;
ð19Þ
dPCNAi
dt
¼ kAsPcP21  p21  PCNAa  kDsPcP21 þ rDep21
 
PCNAi
 kExPc þ kAsRcPcRCp
 
PCNAi þ kDsRcPc þ rDsRc
 
RCi;
ð20Þ
where kImPc and k
Ex
Pc denote the nuclear import and export rates of PCNA,
respectively. The association and dissociation of p21 and free PCNA occur with
rate kAsPcP21 and k
Ds
PcP21, respectively, while the binding and dissociation rates of
PCNA and replication complexes are kAsRcPc and k
Ds
RcPc, respectively. Considering all
the complexes that contain p21 the following conservation equation holds.
p21 ¼ p21t CyP21PCNAi RCi: ð21Þ
DNA damage. In our model, DNA damage (Dam) can either occur randomly,
independent of the cell cycle stage, or speciﬁcally during DNA replication.
dDam
dt
¼ kGeDam þ kGeDam;RCaRCa  rReDam  Dam; ð22Þ
with rReDam ¼ kReDam þ kReDam;p53
p53
jDam þDam : ð23Þ
Here, kGeDam and k
Ge
Dam;RCa correspond to the constitutive and replication-dependent
rate of DNA damage induction, respectively. Damage repair occurs with
a p53-independent rate kReDam
 
and a p53-dependent rate ðkReDam;p53Þ assuming that
p53 expression induces DNA repair processes.
Computation. A deterministic version of the model was prepared using the
Systems Biology Toolbox 2 (ref. 67) for MatLab (version 8.6.0 R2015b) and
simulated with the CVODE routine from SUNDIALS68. Bifurcation diagrams were
calculated using the freely available software XPP-Aut69. Different versions of the
model are available at http://cellcycle.org.uk/publication. The model was also
deposited in the BioModels database70 and assigned the identiﬁer
MODEL1607210001. Kinetic parameters were estimated by comparing
deterministic simulations to experimental time-course data of cell cycle regulators
and to qualitative experimental observations. Parameter values and non-zero initial
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conditions are listed in Supplementary Tables 3 and 4. We simulated a stochastic
version of the model using custom-made MatLab code of the stochastic simulation
algorithm, also known as Gillespie’s algorithm (reviewed in ref. 71) according to
the sorting direct method72. To this end, the rate expressions of the deterministic
model were converted into propensity functions, that requires the transformation
of the relative levels of cell cycle regulators into numbers of molecules. Here,
we followed the system in a control volume containing on average 1,000 molecules
per AU of proteins, 100 molecules per AU of mRNAs and 1 event per AU of
DNA damage. Hence, most of the simulated cell-to-cell variability originates in the
stochastic inﬂiction of DNA damage followed by transcriptional noise, while
translational noise plays only a minor role. To account for the extrinsic noise
observed in our experiments, that is, the variability in p21 levels after cell
division, we multiplied the initial p21 level, the initial p21 mRNA level and the
p53-independent p21 mRNA synthesis rate (kSymRNA in equation (1)) for each cell
(simulation run) by a single random number drawn from a uniform distribution
in the interval (0.1,1). For the simulation of depletion experiments Skp2 and/or
Cdt2 were reduced to 1%.
Code. Newly generated code used for cell tracking and feature extraction, and for
generating our mathematical model is freely available at http://cellcycle.org.uk/
publication
Data availability. The data sets generated during the current study are available
from the corresponding authors on reasonable request.
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